Table 2 CUP subsets and outcome.
From: Angiogenesis in cancer of unknown primary: clinicopathological study of CD34, VEGF and TSP-1
Subgroups | (#) | (%) |
|---|---|---|
   Favorable | 50 | 62 |
   Unfavorable | 31 | 38 |
Treatment | (#) | (%) |
   Chemotherapy | 64 | 78 |
   Radiotherapy | 4 | 6 |
Median survival | (months) | Â |
   All cases | 10.5 |  |
   favourable cases | 11.5 |  |
   unfavorable cases | 8.5 |  |